February 28, 2026 - 02:28

Shares of Axos Financial experienced a sharp decline in Thursday's trading session, mirroring a broader downturn across the financial sector. The digital bank's stock fell nearly 9% following the release of a key government inflation report that exceeded economist forecasts.
The hotter-than-expected Consumer Price Index (CPI) data for March ignited widespread investor concern that the Federal Reserve may delay or reduce the number of anticipated interest rate cuts this year. This sentiment triggered a sell-off across major indices, with rate-sensitive financial stocks bearing a significant portion of the losses.
For banking institutions like Axos, higher-for-longer interest rates present a mixed outlook. While potentially benefiting net interest margins, they also raise concerns about increased pressure on borrowers and a potential slowdown in loan growth. The market's reaction reflects a immediate reassessment of risk within the sector, as traders adjust their portfolios in response to the persistent inflation narrative.
The decline at Axos underscores how macroeconomic indicators remain a primary driver of daily stock volatility, even for companies with direct digital banking models. Investor attention will now likely focus on upcoming earnings reports and management commentary for clues on how individual banks are navigating the current economic landscape.
February 27, 2026 - 23:14
House Finance Committee advances millionaires tax bill to full voteA landmark proposal to institute the first-ever income tax in Washington state has cleared a critical hurdle. The House Finance Committee voted to advance the bill, setting the stage for a full...
February 27, 2026 - 05:38
Super Group (SGHC) Limited (SGHC) Reports Financial Results For Fourth Quarter and Full Year 2025Super Group (SGHC) Limited, the parent company of leading global online sports betting and gaming brands, has released its financial results for the fourth quarter and full year ended December 31,...
February 26, 2026 - 20:17
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent ProgressCRANBURY, N.J., February 26, 2026—Rocket Pharmaceuticals, a late-stage biotechnology firm, has released its financial and operational results for the fourth quarter and full year ending December...
February 26, 2026 - 00:23
New Mountain Finance Q4 Earnings Call HighlightsNew Mountain Finance Corporation has announced its financial results for the fourth quarter, highlighting robust performance and a significant strategic shift. Company management confirmed that the...